13 Essential Tips for Liver Disease Patients As a liver disease patient, it is crucial to be aware of certain aspects that can significantly impact your health. Here are 13 small but important pieces of information that every liver disease patient should know: Stay hydrated:Drinking plenty of wa...
[26] Lucidi C, Ginanni Corradini S, Abraldes JG, et al. Hepatic encephalopathy expands the predictivity of model for end-stage liver disease in liver transplant setting: evidence by means of 2 independent cohorts. Liver Transpl 2016 ...
一项于2022年发表的前瞻性队列研究进一步阐明了实现“再代偿”所需的肝功能稳定改善的判定标准,即终末期肝病模型评分(model for end-stage liver disease,MELD)<10分和(或)肝功能Child-Pugh A级(白蛋白>35 g/L,国际标准化比值<1.50,...
[26] Lucidi C, Ginanni Corradini S, Abraldes JG, et al. Hepatic encephalopathy expands the predictivity of model for end-stage liver disease in liver transplant setting: evidence by means of 2 independent cohorts. Liver Transpl 2016 Oct;22(10):1333–1342. [27] Malinchoc M, Kamath ...
[28] Kamath PS, Kim WR. Advanced liver disease study group. The model for end-stage liver disease (MELD). Hepatology 2007;45:797–805. [29] Bettinger D, Sturm L, Pfaff L, et al. Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival. J Hepatol...
6、肝衰竭:TIPS术后肝衰竭是指总胆红素升高至≥3倍和/或INR升高至≥2倍,并需要进一步干预(如,肝移植)或导致不良结局(即,死亡)。据报道,TIPS术后肝衰竭的发生率为20%。肝衰竭的TIPS术前危险因素包括终末期肝病模型(Model for End-stage Liver Disease, MELD)评分较高(即,MELD>20),以及基础心血管疾病。
TIPS has been in use for more than 20 years to treat thecomplications of portal hypertension and TIPS have beencreated in thousands of patients with liver disease world-wide.Despite the extensive use of TIPS to treat thecomplications of portal hypertension there initially was alack of consensus on...
Portacaval shunt for veno-occlusive disease after allogeneic stem cell transplantation for the treatment of Krabbe disease: an Oldie but Goodie Background: Over 85% of U.S. centers adhere to practice guidelines that consider morbid obesity to be a contraindication to liver transplantation (LT). Th...
In elective situations, such as refractory (intractable ascites (intolerance to diuretics) or resistant ascites (i.e. despite optimal diuretic treatment (spironolactone 400mg/d and Furosemide 160mg/d combined with low-salt treatment (<5.2g/day) or recurrent ascites (the need for at least 3 ...
Liver transplantation alone for unresectable hilar cholangiocarcinoma (CCA) is fraught with frequent recurrence and poor long-term survival. The Mayo Clini... CB Rosen,JK Heimbach,GJ Gores - HPB 被引量: 356发表: 2008年 Vaccination against Hepatitis B in Patients with Chronic Liver Disease Awaiting...